Avalo Therapeutics Inc (AVTX)
14.36
-1.03
(-6.69%)
USD |
NASDAQ |
May 03, 16:00
14.79
+0.43
(+2.99%)
Pre-Market: 08:27
Avalo Therapeutics Total Liabilities (Quarterly): 13.69M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.69M |
| September 30, 2023 | 14.58M |
| June 30, 2023 | 31.20M |
| March 31, 2023 | 42.50M |
| December 31, 2022 | 44.28M |
| September 30, 2022 | 38.58M |
| June 30, 2022 | 38.18M |
| March 31, 2022 | 55.56M |
| December 31, 2021 | 57.13M |
| September 30, 2021 | 55.05M |
| June 30, 2021 | 42.50M |
| March 31, 2021 | 30.19M |
| December 31, 2020 | 19.19M |
| September 30, 2020 | 20.62M |
| June 30, 2020 | 18.63M |
| March 31, 2020 | 18.53M |
| December 31, 2019 | 15.11M |
| September 30, 2019 | 38.97M |
| June 30, 2019 | 41.92M |
| Date | Value |
|---|---|
| March 31, 2019 | 51.75M |
| December 31, 2018 | 49.34M |
| September 30, 2018 | 48.10M |
| June 30, 2018 | 42.93M |
| March 31, 2018 | 40.78M |
| December 31, 2017 | 14.95M |
| September 30, 2017 | 6.083M |
| June 30, 2017 | 2.912M |
| March 31, 2017 | 3.986M |
| December 31, 2016 | 5.562M |
| September 30, 2016 | 8.996M |
| June 30, 2016 | 7.601M |
| March 31, 2016 | 8.048M |
| December 31, 2015 | 8.574M |
| September 30, 2015 | 38.30M |
| June 30, 2015 | 9.906M |
| March 31, 2015 | 38.69M |
| December 31, 2014 | 38.65M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.69M
Minimum
Dec 2023
57.13M
Maximum
Dec 2021
33.50M
Average
38.18M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Imunon Inc | 8.530M |
| iBio Inc | 24.82M |
| Kodiak Sciences Inc | 213.59M |
| Petros Pharmaceuticals Inc | 21.32M |
| Ocugen Inc | 23.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.99M |
| Shareholders Equity (Quarterly) | 7.304M |
| Current Ratio | 1.818 |
| Net Debt Paydown Yield | 52.27% |